Tonix Pharmaceuticals stock halted ahead of FDA approval news
RXO Inc. shares have reached a 52-week low, dipping to $18.73, as market conditions weigh on the logistics company’s performance. The stock has seen significant volatility, with a sharp decline of nearly 25% over the past six months and a 19.4% drop year-to-date. This latest price level reflects a notable decline over the past year, with RXO Inc. experiencing an 11.32% decrease in stock value year-over-year. While investors are closely monitoring the company’s strategic moves and industry trends to gauge potential recovery, InvestingPro analysis suggests potential upside ahead, with analysts forecasting both sales and net income growth this year. For deeper insights into RXO’s valuation and growth prospects, InvestingPro offers 11 additional investment tips and a comprehensive Pro Research Report.
In other recent news, RXO Inc. reported its fourth-quarter results, which included adjusted earnings per share of $0.06, aligning with analyst expectations. The company achieved revenues of $1.67 billion, slightly surpassing the consensus forecast of $1.66 billion, driven by the acquisition of Coyote Logistics. Despite this revenue beat, RXO’s outlook for the first quarter of 2025 was less optimistic, with an expected adjusted EBITDA range of $20 million to $30 million. The company’s brokerage gross margin is projected at 12-14% for the same period.
Barclays (LON:BARC) analyst Brandon Oglenski adjusted RXO’s stock price target to $24 from $30 while maintaining an Overweight rating, following RXO’s earnings announcement. The revision reflects expectations of increased transportation costs and reduced managed transportation revenue. RXO’s gross margin fell to 15.5% in Q4, down from 18% the previous year, indicating ongoing challenges in the freight market. CEO Drew Wilkerson noted that the integration of Coyote Logistics is progressing ahead of schedule, with an updated estimate of achieving at least $50 million in annualized cost synergies. Despite a 10% sequential increase in combined brokerage volume, the company experienced a 6% year-over-year decline in overall volume.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.